Marsh & McLennan [MMC] vs Erie Indemnity [ERIE] Detailed Stock Comparison
Marsh & McLennan
NYSE
Loading...
Erie Indemnity
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Marsh & McLennan wins in 11 metrics, Erie Indemnity wins in 8 metrics, with 0 ties. Marsh & McLennan appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Marsh & McLennan | Erie Indemnity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.32 | 30.37 | Marsh & McLennan |
| Price-to-Book Ratio | 6.58 | 8.69 | Marsh & McLennan |
| Debt-to-Equity Ratio | 135.27 | 1.61 | Erie Indemnity |
| PEG Ratio | 3.21 | 4.65 | Marsh & McLennan |
| EV/EBITDA | 16.34 | 23.93 | Marsh & McLennan |
| Profit Margin (TTM) | 16.00% | 15.73% | Marsh & McLennan |
| Operating Margin (TTM) | 26.91% | 19.32% | Marsh & McLennan |
| EBITDA Margin (TTM) | 26.91% | 19.32% | Marsh & McLennan |
| Return on Equity | 28.41% | 31.14% | Erie Indemnity |
| Return on Assets (TTM) | 7.86% | 15.57% | Erie Indemnity |
| Free Cash Flow (TTM) | $3.99B | $486.40M | Marsh & McLennan |
| Dividend Yield | 1.51% | 1.86% | Erie Indemnity |
| 1-Year Return | -5.72% | -25.12% | Marsh & McLennan |
| Price-to-Sales Ratio (TTM) | 4.02 | 4.78 | Marsh & McLennan |
| Enterprise Value | $123.84B | $18.81B | Marsh & McLennan |
| EV/Revenue Ratio | 4.80 | 4.73 | Erie Indemnity |
| Gross Profit Margin (TTM) | 44.15% | N/A | N/A |
| Revenue per Share (TTM) | $52 | $76 | Erie Indemnity |
| Earnings per Share (Diluted) | $8.33 | $11.95 | Erie Indemnity |
| Beta (Stock Volatility) | 0.78 | 0.32 | Erie Indemnity |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Marsh & McLennan vs Erie Indemnity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Marsh & McLennan | -0.27% | 1.61% | 0.12% | -7.84% | -9.58% | -0.37% |
| Erie Indemnity | 1.82% | -0.04% | 0.62% | 5.05% | -6.14% | -10.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Marsh & McLennan | -5.72% | 26.87% | 84.69% | 288.97% | 778.76% | 680.68% |
| Erie Indemnity | -25.12% | 68.29% | 76.55% | 343.11% | 601.97% | 596.37% |
Performance & Financial Health Analysis: Marsh & McLennan vs Erie Indemnity
| Metric | MMC | ERIE |
|---|---|---|
| Market Information | ||
| Market Cap | $103.70B | $18.98B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,292,330 | 135,263 |
| 90 Day Avg. Volume | 2,608,213 | 143,881 |
| Last Close | $210.55 | $366.36 |
| 52 Week Range | $196.27 - $248.00 | $332.34 - $547.00 |
| % from 52W High | -15.10% | -33.02% |
| All-Time High | $248.00 (Mar 31, 2025) | $547.00 (Sep 23, 2024) |
| % from All-Time High | -15.10% | -33.02% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.07% |
| Quarterly Earnings Growth | 0.08% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.16% |
| Operating Margin (TTM) | 0.27% | 0.19% |
| Return on Equity (TTM) | 0.28% | 0.31% |
| Debt to Equity (MRQ) | 135.27 | 1.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $32.07 | $41.78 |
| Cash per Share (MRQ) | $3.41 | $7.48 |
| Operating Cash Flow (TTM) | $4.92B | $688.32M |
| Levered Free Cash Flow (TTM) | $4.34B | $400.57M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.51% | 1.86% |
| Last 12-Month Dividend | $3.24 | $6.71 |
Valuation & Enterprise Metrics Analysis: Marsh & McLennan vs Erie Indemnity
| Metric | MMC | ERIE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.32 | 30.37 |
| Forward P/E | 22.37 | 27.09 |
| PEG Ratio | 3.21 | 4.65 |
| Price to Sales (TTM) | 4.02 | 4.78 |
| Price to Book (MRQ) | 6.58 | 8.69 |
| Market Capitalization | ||
| Market Capitalization | $103.70B | $18.98B |
| Enterprise Value | $123.84B | $18.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.80 | 4.73 |
| Enterprise to EBITDA | 16.34 | 23.93 |
| Risk & Other Metrics | ||
| Beta | 0.78 | 0.32 |
| Book Value per Share (MRQ) | $32.07 | $41.78 |
Financial Statements Comparison: Marsh & McLennan vs Erie Indemnity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MMC | ERIE |
|---|---|---|
| Revenue/Sales | $7.06B | $1.22B |
| Cost of Goods Sold | $3.85B | N/A |
| Gross Profit | $3.21B | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $2.01B | N/A |
| EBITDA | $2.29B | N/A |
| Pre-Tax Income | $1.83B | $174.75M |
| Income Tax | $415.00M | $36.33M |
| Net Income (Profit) | $1.41B | $138.42M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MMC | ERIE |
|---|---|---|
| Cash & Equivalents | $1.60B | $235.22M |
| Total Current Assets | $22.46B | N/A |
| Total Current Liabilities | $19.78B | N/A |
| Long-Term Debt | $20.43B | N/A |
| Total Shareholders Equity | $14.27B | $2.07B |
| Retained Earnings | $25.88B | $3.24B |
| Property, Plant & Equipment | $3.91B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MMC | ERIE |
|---|---|---|
| Operating Cash Flow | $1.27B | N/A |
| Capital Expenditures | N/A | $-29.67M |
| Free Cash Flow | $-677.00M | $88.44M |
| Debt Repayment | $-505.00M | N/A |
| Common Stock Repurchase | $-300.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MMC | ERIE |
|---|---|---|
| Shares Short | 5.98M | 1.75M |
| Short Ratio | 2.21 | 11.61 |
| Short % of Float | 0.01% | 0.07% |
| Average Daily Volume (10 Day) | 2,292,330 | 135,263 |
| Average Daily Volume (90 Day) | 2,608,213 | 143,881 |
| Shares Outstanding | 491.40M | 52.29M |
| Float Shares | 490.71M | 19.54M |
| % Held by Insiders | 0.00% | 0.45% |
| % Held by Institutions | 0.93% | 0.52% |
Dividend Analysis & Yield Comparison: Marsh & McLennan vs Erie Indemnity
| Metric | MMC | ERIE |
|---|---|---|
| Last 12-Month Dividend | $3.24 | $6.71 |
| Last 12-Month Dividend Yield | 1.51% | 1.86% |
| 3-Year Avg Annual Dividend | $2.58 | $5.46 |
| 3-Year Avg Dividend Yield | 0.36% | 0.40% |
| 3-Year Total Dividends | $7.73 | $16.39 |
| Ex-Dividend Date | Apr 03, 2025 | Oct 06, 2025 |